Prostaglandin E1 treatment of angina pectoris.doc

 PAGE \* MERGEFORMAT 7 Prostaglandin E1 treatment of angina pectoris [Abstract] Objective: To observe the prostaglandin E1 (PGE1 clinical efficacy of treatment of angina pectoris. Methods: 94 patients with angina pectoris on the basis of routine treatment, 46 patients were divided into study group and control group, 48 patients in the observation group application to join PGE1100g 250mL 0.9% saline injection in 15 to 20 drops / minute infusion, day 1, once every 2 weeks as 1 course of treatment, control group of compound Danshen injection 20mL 0.9% saline intravenously injection 250mL day 1, once every 2 weeks as 1 course of treatment, observation and treatment before and after the relief of angina, ST-T changes in electrocardiogram and blood lipids, blood rheology changes. Results: The response rate of angina pectoris group, ECG ST- T changes compared with the control group significant difference (P lt;0.01, the observation group of lipids, plasma viscosity compared with the control group were decreased (P lt;0.01. CONCLUSIONS: Prostaglandin E1 treatment of angina obvious value. [Keywords:] prostaglandin E1, compound Danshen injection, angina, coronary heart disease Angina in the elderly population have a higher prevalence, if not control, is likely to develop into acute myocardial infarction, 2002 in Our Hospital May 2004 prostaglandin E1 (PGE1 treatment of angina pectoris 46 cases, satisfactory outcome, are as follows. 1 Materials and Methods 1.1 Clinical data select 94 cases of patients with angina pectoris (coronary heart disease are in line with WHO recommended standards for naming and diagnosis of 46 patients were randomly divided into two groups and the control group 48 cases. The observation group 32 males and 14 females, aged 41 ~ 77 years, average 61.8 years old. the control group, 33 males and 15 females, aged 42 to 76 years, mean 62.3 years old. the two groups for age, sex, hyperlipidemia, hypertension and smoking were not significa